Cet anticorps anti-VEGFA Monoclonal Souris (Clone 7G7) (ABIN155175) détecte spécifiquement VEGFA dans WB et EIA.
L’anticorps est réactif avec des échantillons de Humain.
VEGFA
Reactivité: Humain
WB, ELISA, Neut
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA: Use at 1-15 μg/mL. Western blot: Use at 1-2 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Reconstitution
Restore in sterile water to a concentration of 1.0 mg/mL.
Buffer
PBS, pH 7.4 without preservative or stabilizer.
Agent conservateur
Without preservative
Stock
4 °C
Stockage commentaire
The lyophilized antibody, thought stable at room temperature, is best stored desiccated below 0 °C. Reconstituted anti-VEGF-A is stable at 4 °C for six weeks or can be stored in working aliquots at - 20 °C for longer.
Antigène
VEGFA
(Vascular Endothelial Growth Factor A (VEGFA))
Autre désignation
VEGF-A
Sujet
VEGFA is a member of the PDGF/VEGF growth factor family and is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternate transcriptional splice variants, encoding either freely secreted or cell associated isoforms, have been characterized. There is also evidence for the use of non AUG (CUG) translation initiation sites upstream of, and in frame with the first AUG, leading to additional isoforms.Synonyms: VEGF, VEGFA, VPF, Vascular endothelial growth factor A, Vascular permeability factor